MULTAQ® (Dronedarone Hydrochloride Tablets): Clinical Trials

2 trials of MULTAQ® (Dronedarone Hydrochloride Tablets), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2

Follow MULTAQ® (Dronedarone Hydrochloride Tablets): new trials by email Literature Review of MULTAQ® (Dronedarone Hydrochloride Tablets) trials Research Report on MULTAQ® (Dronedarone Hydrochloride Tablets)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bioequivalence Study of Dronedarone Hydrochloride Tablets in Healthy Subjects Under Fasting Conditions
Dronedarone Hydrochloride Tablets, MULTAQ® (Dronedarone Hydrochloride Tablets) - Atrial Fibrillation (AF)
Not applicableCompletedShandong New Time Pharmaceutical Co., LTD512023-06-052026-02-09
Bioequivalence Study of Dronedarone Hydrochloride Tablets
Dronedarone Hydrochloride Tablets, MULTAQ® (Dronedarone Hydrochloride Tablets) - Atrial Fibrillation (AF)
Not applicableCompletedShandong New Time Pharmaceutical Co., LTD482022-11-142026-02-09

Conditions studied

Atrial Fibrillation (2)

Sponsors

Shandong New Time Pharmaceutical Co., LTD (2)

Countries

China (2)